AZD-9164
- Generic Name
- AZD-9164
- Drug Type
- Small Molecule
- Chemical Formula
- C29H38FN2O2
- CAS Number
- 1034978-04-5
- Unique Ingredient Identifier
- 977LWC4O5D
- Background
AZD9164 has been used in trials studying the basic science and treatment of Chronic Obstructive Pulmonary Disease.
A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects
- First Posted Date
- 2010-03-31
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 27
- Registration Number
- NCT01096563
- Locations
- 🇬🇧
Research Site, Croydon, United Kingdom
The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary Disease
Phase 2
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- First Posted Date
- 2009-07-14
- Last Posted Date
- 2011-08-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 25
- Registration Number
- NCT00939211
- Locations
- 🇸🇪
Research Site, Lund, Sweden
AZD9164 Single Ascending Dose Study in Healthy Male Subjects
- First Posted Date
- 2009-02-19
- Last Posted Date
- 2009-09-23
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 65
- Registration Number
- NCT00847249
- Locations
- 🇸🇪
Research Site, Lund, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath